Calliditas Therapeutics AB (publ) (CALT)
USD 40.0
(-0.1%)
USD 40.0
(-0.1%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.12 Billion SEK | 43.44% |
| 2022 | 787.67 Million SEK | 243.44% |
| 2021 | 229.34 Million SEK | 26141.08% |
| 2020 | 874 Thousand SEK | -99.53% |
| 2019 | 184.82 Million SEK | 362509.8% |
| 2018 | -51 Thousand SEK | 0.0% |
| 2017 | -51 Thousand SEK | 99.91% |
| 2016 | -56.02 Million SEK | -10.04% |
| 2015 | -50.91 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 281.46 Million SEK | -34.43% |
| 2024 Q2 | 506.33 Million SEK | 79.89% |
| 2023 Q3 | 279.67 Million SEK | 9.6% |
| 2023 Q4 | 429.26 Million SEK | 53.49% |
| 2023 Q2 | 255.17 Million SEK | 39.95% |
| 2023 Q1 | 182.32 Million SEK | -56.71% |
| 2023 FY | 1.12 Billion SEK | 43.44% |
| 2022 Q1 | 49.12 Million SEK | 57.54% |
| 2022 Q2 | 61.66 Million SEK | 25.53% |
| 2022 FY | 787.67 Million SEK | 243.44% |
| 2022 Q4 | 421.16 Million SEK | 64.69% |
| 2022 Q3 | 255.73 Million SEK | 314.74% |
| 2021 FY | 229.34 Million SEK | 26141.08% |
| 2021 Q1 | - SEK | -100.0% |
| 2021 Q4 | 31.18 Million SEK | -84.27% |
| 2021 Q3 | 198.16 Million SEK | 0.0% |
| 2021 Q2 | - SEK | 0.0% |
| 2020 FY | 874 Thousand SEK | -99.53% |
| 2020 Q2 | - SEK | -100.0% |
| 2020 Q1 | 474 Thousand SEK | -98.98% |
| 2020 Q3 | - SEK | 0.0% |
| 2020 Q4 | 400 Thousand SEK | 0.0% |
| 2019 Q4 | 46.58 Million SEK | 0.0% |
| 2019 Q2 | 138.24 Million SEK | 0.0% |
| 2019 Q1 | - SEK | 0.0% |
| 2019 FY | 184.82 Million SEK | 362509.8% |
| 2019 Q3 | - SEK | -100.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2018 FY | -51 Thousand SEK | 0.0% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2017 FY | -51 Thousand SEK | 99.91% |
| 2017 Q3 | - SEK | 0.0% |
| 2016 FY | -56.02 Million SEK | -10.04% |
| 2015 FY | -50.91 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -5264.565% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 487096.121% |
| Vaxxinity, Inc. | -2.23 Million USD | 50674.351% |
| IO Biotech, Inc. | -756 Thousand USD | 149548.545% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -5534.505% |
| MEI Pharma, Inc. | 49.32 Million USD | -2190.492% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 1114.084% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -219284.66% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 9415358.333% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 170255.271% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 28761.016% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -1092.774% |
| Agenus Inc. | 139.61 Million USD | -709.248% |
| AlloVir, Inc. | -398 Thousand USD | 283977.136% |
| CRISPR Therapeutics AG | 240.95 Million USD | -368.895% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -735.248% |
| NextCure, Inc. | -3.68 Million USD | 30768.594% |
| Opthea Limited | 21.72 Thousand USD | -5201700.184% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 2556972.907% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -929.252% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -5144.052% |
| Senti Biosciences, Inc. | -2.68 Million USD | 42210.734% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -837.821% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 2226806.74% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 25.565% |
| BioLineRx Ltd. | 1.1 Million USD | -101870.307% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 59879.418% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -140776.683% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 197968.827% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 2512.159% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -25707.012% |
| AbCellera Biologics Inc. | 38.02 Million USD | -2871.285% |
| ADMA Biologics, Inc. | 88.21 Million USD | -1180.726% |
| Aptorum Group Limited | -1.11 Million USD | 101458.497% |
| AnaptysBio, Inc. | 14.78 Million USD | -7543.806% |
| Ardelyx, Inc. | 106.66 Million USD | -959.273% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -369.326% |
| Bicycle Therapeutics plc | -129.52 Million USD | 972.322% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -941425.833% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 1265.375% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -14254.351% |
| Chimerix, Inc. | 324 Thousand USD | -348613.272% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 3725.011% |
| Dyadic International, Inc. | 922.95 Thousand USD | -122314.262% |
| Elevation Oncology, Inc. | -39 Thousand USD | 2897102.564% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 953616.301% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1852.934% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 1250.974% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 788532.042% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1852.934% |
| ChromaDex Corporation | 50.78 Million USD | -2124.953% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 30702.14% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 1556.005% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 1164.643% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -185422.332% |
| Incyte Corporation | 3.44 Billion USD | 67.162% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 42391.565% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 768692.517% |
| Jaguar Health, Inc. | 7.72 Million USD | -14527.538% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 66.756% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 2054338.182% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -843.468% |
| ContextLogic Inc. | 59 Million USD | -1814.968% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 646297.446% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 214489.184% |
| MiMedx Group, Inc. | 266.84 Million USD | -323.407% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -3788.594% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 119133.075% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -6715.654% |
| Onconetix, Inc. | -1.12 Million USD | 100336.523% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 4000.273% |
| Psyence Biomedical Ltd. | -240.00 USD | 470763016.667% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 1970987.555% |
| Precigen, Inc. | 106 Thousand USD | -1065778.302% |
| Pharming Group N.V. | 220.1 Million USD | -413.317% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -111875.322% |
| PureTech Health plc | -1.6 Million USD | 70582.283% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 31917.263% |
| Royalty Pharma plc | 1.79 Billion USD | 37.018% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -15978.426% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 2592.732% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 5238.632% |
| Acelyrin, Inc. | -115 Thousand USD | 982561.739% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 11241080.997% |
| Pyxis Oncology, Inc. | -2 Million USD | 56591.55% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 218743.395% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 1250.342% |
| TG Therapeutics, Inc. | 219.1 Million USD | -415.65% |
| Alkermes plc | 1.37 Billion USD | 17.811% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -3778.715% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 65445.922% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -43793.978% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -5833.052% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -227688.508% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -985.343% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 722.812% |
| Geron Corporation | -123.5 Million USD | 1014.821% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 1377942.683% |
| Summit Therapeutics Inc. | -2.05 Million USD | 55213.707% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -27790.175% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 23647.957% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 8558.181% |
| Innoviva, Inc. | 261.06 Million USD | -332.778% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 22596720.0% |
| Vaxcyte, Inc. | -75 Million USD | 1606.441% |
| Molecular Templates, Inc. | 50.39 Million USD | -2141.951% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -266369.575% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -3744.663% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 229740.447% |
| Novavax, Inc. | 639.93 Million USD | -76.553% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 5029.67% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -260.195% |
| Precision BioSciences, Inc. | 40.47 Million USD | -2691.636% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| ImmuCell Corporation | 4.39 Million USD | -25599.682% |
| Immix Biopharma, Inc. | -5468.00 USD | 20662700.585% |
| Mesoblast Limited | -9.81 Million USD | 11611.268% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 16017.597% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 238187.22% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 10863859.615% |
| Soligenix, Inc. | 97.31 Thousand USD | -1160951.68% |
| Century Therapeutics, Inc. | -10.8 Million USD | 10552.688% |
| Kura Oncology, Inc. | -849 Thousand USD | 133177.856% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 1783.701% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -1040.794% |
| Autolus Therapeutics plc | -4.86 Million USD | 23314.115% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -2629.984% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 672618.452% |
| GRI Bio, Inc. | 10.84 Million USD | -10321.834% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -44381.781% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 13105.997% |
| IGM Biosciences, Inc. | -211.66 Million USD | 633.795% |
| INmune Bio, Inc. | 155 Thousand USD | -728823.226% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -1724.103% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 75107.485% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 174334.564% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 3859603.314% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -280952.488% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 56704.76% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 361068.371% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -1096.082% |
| Verastem, Inc. | -62 Thousand USD | 1822408.065% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -46299.63% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 432985.441% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -37225.107% |
| Histogen Inc. | 3.76 Million USD | -29876.943% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -195990.278% |
| Surrozen, Inc. | -27.23 Million USD | 4249.214% |
| Organovo Holdings, Inc. | -5.38 Million USD | 21065.504% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 93871.247% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 4505.314% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 57062271.717% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -18524.336% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 1683124.236% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -629.907% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -774818.381% |
| Apollomics, Inc. | 127 Thousand USD | -889530.709% |
| Amarin Corporation plc | 165.54 Million USD | -582.508% |
| Turnstone Biologics Corp. | 16.5 Million USD | -6744.972% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 1122.573% |
| Synaptogenix, Inc. | -6347.00 USD | 17801124.106% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 2215454.902% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -600.171% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 35.72% |
| Better Therapeutics, Inc. | -2.72 Million USD | 41500.916% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 1107.33% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -234.189% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 9903948.177% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 18148.419% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 102070.307% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -15339.066% |
| Insmed Incorporated | 239.63 Million USD | -371.48% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -31477.166% |
| OmniAb, Inc. | 14.66 Million USD | -7603.218% |
| Alector, Inc. | -95.05 Million USD | 1288.633% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -799.397% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 2699.524% |
| Zai Lab Limited | 170.9 Million USD | -561.095% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -1279.913% |
| Aura Biosciences, Inc. | -1.29 Million USD | 87345.637% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -869000.769% |
| Immunic, Inc. | -111 Thousand USD | 1017965.766% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -7026.473% |
| Veracyte, Inc. | 248.14 Million USD | -355.305% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 116.166% |
| FibroGen, Inc. | 128.9 Million USD | -776.49% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 200324745.39% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 9784.084% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -290344.987% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -217.953% |
| Galecto, Inc. | -830 Thousand USD | 136224.217% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 81676.245% |
| Fortrea Holdings Inc. | 424 Million USD | -166.47% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 1411.211% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 199364.727% |
| XBiotech Inc. | -1.74 Million USD | 64883.888% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 102070.307% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 2531.26% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 1595.791% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -1439.216% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -6623.984% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -190.415% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 2375.729% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -245.777% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 10077.453% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -4520.797% |
| NexImmune, Inc. | -1.02 Million USD | 110330.426% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -20922696.296% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 16000.446% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 90.003% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 1690780.414% |
| Ainos, Inc. | -253.73 Thousand USD | 445383.428% |
| Pluri Inc. | 322 Thousand USD | -350779.193% |
| Prothena Corporation plc | -129.2 Million USD | 974.475% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -2140.664% |
| Celularity Inc. | 6.75 Million USD | -16625.848% |
| Rallybio Corporation | -150 Thousand USD | 753320.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 3564.995% |
| MeiraGTx Holdings plc | 287 Thousand USD | -393569.338% |
| Omeros Corporation | -69.77 Million USD | 1719.156% |
| Humacyte, Inc. | -76.55 Million USD | 1575.939% |
| Immunocore Holdings plc | 248.39 Million USD | -354.86% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 7548.289% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -1711.149% |
| Blueprint Medicines Corporation | 236.58 Million USD | -377.56% |
| CalciMedica, Inc. | -58 Thousand USD | 1948084.483% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 79330.785% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 39826.828% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 3760.557% |
| Pulmatrix, Inc. | -8.22 Million USD | 13844.903% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 96666.752% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 283265.664% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 383.312% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -40606.049% |
| Cytokinetics, Incorporated | -322.59 Million USD | 450.234% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -130954.918% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 331428.739% |
| Vor Biopharma Inc. | -3.49 Million USD | 32454.84% |
| Roivant Sciences Ltd. | 109.23 Million USD | -934.312% |
| Evogene Ltd. | 1.39 Million USD | -80659.9% |
| ProKidney Corp. | -3.16 Million USD | 35752.603% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 2672.944% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -16377.045% |
| CorMedix Inc. | -205.56 Thousand USD | 549730.282% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 1536.147% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 3423830.303% |
| Atai Life Sciences N.V. | -5000.00 USD | 22596720.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 927262.54% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 1177007.292% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 81441.325% |
| Sagimet Biosciences Inc. | 2 Million USD | -56391.55% |
| MediciNova, Inc. | 979.7 Thousand USD | -115223.592% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 1439.948% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1194992.919% |
| GeoVax Labs, Inc. | -20.72 Million USD | 5552.651% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -362.032% |
| Biomea Fusion, Inc. | -4.2 Million USD | 26994.335% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -29.518% |
| Mereo BioPharma Group plc | 7.42 Million USD | -15114.53% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 364561.613% |
| Absci Corporation | -41.84 Million USD | 2799.78% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 22596720.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 1579.359% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 46009.427% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -428.613% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 120167.056% |
| Allakos Inc. | -6.14 Million USD | 18498.16% |
| Imunon, Inc. | -720 Thousand USD | 157019.883% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 1737.531% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -137.412% |
| BioAtla, Inc. | -103.73 Million USD | 1189.193% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 9903948.177% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 634836.517% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 565.298% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 363389.711% |
| XOMA Corporation | 3.86 Million USD | -29162.652% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 1712.087% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -7537.089% |
| aTyr Pharma, Inc. | -2.38 Million USD | 47412.856% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -8967.665% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 3896068.966% |
| Viridian Therapeutics, Inc. | -1 Million USD | 112186.409% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -8691007592.308% |
| Akari Therapeutics, Plc | -4000.00 USD | 28245875.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -77.398% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -580169.429% |
| UroGen Pharma Ltd. | 73.35 Million USD | -1440.287% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 4332.528% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -9731433.161% |
| Orgenesis Inc. | -5.72 Million USD | 19835.039% |
| Entera Bio Ltd. | -56 Thousand USD | 2017655.357% |
| GH Research PLC | -315 Thousand USD | 358776.508% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 597894.18% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 215305.905% |
| Xencor, Inc. | -85.26 Million USD | 1425.16% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 511388.958% |
| Replimune Group, Inc. | -2.65 Million USD | 42654.84% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 112943.625% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -535.293% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -580169.429% |
| Portage Biotech Inc. | -54 Thousand USD | 2092379.63% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1194992.919% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 299789.92% |
| OncoCyte Corporation | 413 Thousand USD | -273466.828% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 25135383.648% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 508932982.883% |
| Purple Biotech Ltd. | -196 Thousand USD | 576544.388% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -12498.472% |
| scPharmaceuticals Inc. | 9.78 Million USD | -11450.102% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 10917.0% |
| HilleVax, Inc. | -2.15 Million USD | 52504.035% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 1164874.227% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 7530298.614% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 169236.377% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 4912408.696% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 15052150.582% |
| Savara Inc. | -44.26 Million USD | 2652.598% |
| Curis, Inc. | 9.81 Million USD | -11415.962% |
| Daré Bioscience, Inc. | 2.76 Million USD | -40695.162% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 905500.359% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 495639.912% |
| BeiGene, Ltd. | 2.07 Billion USD | 45.651% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 40510.279% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 382.695% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -1893.069% |
| Erasca, Inc. | -3.73 Million USD | 30374.143% |
| bluebird bio, Inc. | -4.03 Million USD | 28135.509% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 4004037.203% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 40.672% |
| DBV Technologies S.A. | 15.72 Million USD | -7083.564% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 4004037.203% |
| Moderna, Inc. | 2.15 Billion USD | 47.572% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 123578.798% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -14012.303% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 210889.366% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -744.494% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 18258.647% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 2971.746% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 1116.693% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 31589.158% |
| MacroGenics, Inc. | 50.52 Million USD | -2136.094% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 18627.894% |
| Prime Medicine, Inc. | -147.9 Million USD | 863.89% |
| Aditxt, Inc. | -111.66 Thousand USD | 1011949.364% |
| Adagene Inc. | 18.11 Million USD | -6138.2% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -231422.746% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -705.859% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -615.826% |
| SciSparc Ltd. | 2.19 Million USD | -51349.499% |
| Vericel Corporation | 135.57 Million USD | -733.356% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 4510583.452% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 3646833.587% |
| Generation Bio Co. | -73.91 Million USD | 1628.637% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 258642.563% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -1968.568% |
| Invivyd, Inc. | -2.02 Million USD | 55811.588% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 475.558% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 1092378.466% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -1072.413% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -1049.511% |
| Clene Inc. | 533 Thousand USD | -211875.797% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -4586.31% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 118159.666% |
| GeoVax Labs, Inc. | -20.72 Million USD | 5552.651% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -56732.545% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 581540.026% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -2168.509% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 16031.063% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 135247.249% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -1254.47% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -1545242.762% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -2025.261% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 752.373% |
| Trevena, Inc. | 1.45 Million USD | -77551.615% |
| Surrozen, Inc. | -27.23 Million USD | 4249.214% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 320165.439% |
| Cingulate Inc. | -582.91 Thousand USD | 193923.316% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 3644716.129% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 5835.474% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 14925212.285% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 128344.154% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -65.979% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 114455.364% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 2005408.651% |
| Kronos Bio, Inc. | 1.37 Million USD | -82249.198% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 2205.301% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 387028.425% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 231473.87% |
| ImmunityBio, Inc. | -17.89 Million USD | 6415.433% |
| Korro Bio, Inc. | -3.63 Million USD | 31224.821% |
| Kineta, Inc. | 5.43 Million USD | -20695.711% |
| BioVie Inc. | -229.37 Thousand USD | 492665.078% |
| Codexis, Inc. | 57.33 Million USD | -1870.613% |
| Celularity Inc. | 6.75 Million USD | -16625.848% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -28054.274% |
| Celcuity Inc. | -142.77 Thousand USD | 791453.347% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -2233208.954% |
| Cibus, Inc. | 1.42 Million USD | -79353.657% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 302193.85% |
| IN8bio, Inc. | -2.5 Million USD | 45275.17% |
| Kodiak Sciences Inc. | -25.94 Million USD | 4454.38% |
| Annexon, Inc. | -3.26 Million USD | 34683.134% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 55375.489% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 2807.025% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -176436.094% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -45.127% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -553.251% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 59564.789% |
| Arcellx, Inc. | 108.27 Million USD | -943.444% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 3590.472% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -1326.482% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 5441.485% |
| Moolec Science SA | -143.3 Thousand USD | 788510.035% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 2769.859% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -34272.711% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 1711.972% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 31280028.018% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -488177.85% |
| Humacyte, Inc. | -76.55 Million USD | 1575.939% |
| 89bio, Inc. | -273 Thousand USD | 413957.509% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 89983.134% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 133334.788% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 918661.789% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -100867.918% |
| Notable Labs, Ltd. | 113 Thousand USD | -999750.442% |
| Liquidia Corporation | 14.6 Million USD | -7638.568% |
| Mustang Bio, Inc. | -2.22 Million USD | 50878.921% |
| Immunovant, Inc. | -231 Thousand USD | 489204.329% |
| Quantum-Si incorporated | 488 Thousand USD | -231422.746% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 2133.57% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 3766203.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -60578.357% |
| Acasti Pharma Inc. | -11 Thousand USD | 10271290.909% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 552268.686% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 174334.564% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 774.478% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -99481.431% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 296643.57% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 57803.32% |
| PepGen Inc. | -1.18 Million USD | 95524.916% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 889730.709% |
| United Therapeutics Corporation | 2.07 Billion USD | 45.419% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 5034.406% |
| Solid Biosciences Inc. | -76.56 Million USD | 1575.688% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 1368215.714% |
| Immuneering Corporation | -764.13 Thousand USD | 147956.932% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -1704944.972% |
| Belite Bio, Inc | -399 Thousand USD | 283265.664% |
| XOMA Corporation | 3.86 Million USD | -29162.652% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 5739.005% |
| Bionomics Limited | -434.44 Thousand USD | 260160.675% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 105298.417% |
| uniQure N.V. | 2.21 Million USD | -50908.172% |
| Cassava Sciences, Inc. | -89.42 Million USD | 1363.468% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 1327.157% |
| Forte Biosciences, Inc. | -9000.00 USD | 12553777.778% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 135409.102% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 258642.563% |
| Altimmune, Inc. | -65.37 Million USD | 1828.284% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -212.082% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 105298.417% |
| Compugen Ltd. | 31.45 Million USD | -3491.896% |
| Peak Bio, Inc. | 367.76 Thousand USD | -307112.136% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -4508.545% |
| Benitec Biopharma Inc. | 108 Thousand USD | -1046039.815% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 1448601.282% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 94017.789% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 62110.483% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 949537.815% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 94017.789% |
| Instil Bio, Inc. | -4.75 Million USD | 23855.908% |
| argenx SE | 1.1 Billion USD | -1.926% |
| Immunome, Inc. | -8.9 Million USD | 12784.754% |
| Verona Pharma plc | -679.62 Thousand USD | 166343.541% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 645717.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | 47472.369% |
| CervoMed Inc. | -1.29 Million USD | 87438.236% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 47039.385% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 23751.476% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -45623.634% |
| Moolec Science SA | -143.3 Thousand USD | 788510.035% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 276999.003% |
| Design Therapeutics, Inc. | -537 Thousand USD | 210496.834% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 264697.424% |
| NeurAxis, Inc. | 2.15 Million USD | -52286.929% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -52548.229% |
| Lumos Pharma, Inc. | 2 Million USD | -56194.519% |
| Achilles Therapeutics plc | -4.73 Million USD | 23980.094% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 645717.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 1069256.376% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -3468.779% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -130954.918% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 109579.748% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 2580.528% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -2627413.953% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 137549.027% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 8586746.907% |
| Palisade Bio, Inc. | 246 Thousand USD | -459180.894% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 3423830.303% |
| Beam Therapeutics Inc. | -59.67 Million USD | 1993.402% |
| Neurogene Inc. | -3.26 Million USD | 34736.143% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -710.874% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -2724.578% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 380514.478% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 28156.137% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 11910.903% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -7924.368% |
| Athira Pharma, Inc. | -969 Thousand USD | 116697.626% |
| Vaccinex, Inc. | -16 Million USD | 7159.679% |
| HCW Biologics Inc. | -574.82 Thousand USD | 196652.51% |
| XOMA Corporation | 3.86 Million USD | -29162.652% |
| Nektar Therapeutics | 53.47 Million USD | -2012.702% |
| Arvinas, Inc. | 71.8 Million USD | -1473.581% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 1453.723% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 1899.81% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 350979.193% |
| Rezolute, Inc. | -36 Thousand USD | 3138519.444% |
| Clene Inc. | 533 Thousand USD | -211875.797% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 87993168.536% |
| BeyondSpring Inc. | 1.75 Million USD | -64424.9% |
| Synlogic, Inc. | -1.92 Million USD | 58823.025% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 3053697.297% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 17943.193% |
| Peak Bio, Inc. | 367.76 Thousand USD | -307112.136% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 6058.082% |
| Krystal Biotech, Inc. | 47.6 Million USD | -2273.345% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -700.782% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -22384.199% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 43735.977% |
| MannKind Corporation | 136.19 Million USD | -729.593% |
| Ikena Oncology, Inc. | -50.49 Million USD | 2337.644% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -938.314% |
| Gossamer Bio, Inc. | -4.38 Million USD | 25865.815% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 448445.635% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 22596720.0% |
| Legend Biotech Corporation | 140.92 Million USD | -701.702% |
| Mural Oncology plc | -2.56 Million USD | 44113.674% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 205150.998% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 1129931.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -5343.919% |
| REGENXBIO Inc. | 53.02 Million USD | -2030.591% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 21190.926% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 587406.563% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 65332.737% |
| Vaxart, Inc. | -60.76 Million USD | 1959.406% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 430053.193% |
| Cellectis S.A. | 18 Thousand USD | -6276738.889% |
| Longeveron Inc. | 221 Thousand USD | -511135.747% |
| Repare Therapeutics Inc. | -80.07 Million USD | 1511.054% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -3.37% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 87413.06% |
| Revolution Medicines, Inc. | -399.66 Million USD | 382.695% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 3228188.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -2305677.551% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 86.873% |
| Denali Therapeutics Inc. | -93.34 Million USD | 1310.382% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 4510583.452% |
| Veru Inc. | 7.56 Million USD | -14833.145% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 748332.45% |
| Cingulate Inc. | -582.91 Thousand USD | 193923.316% |
| Passage Bio, Inc. | -3.72 Million USD | 30463.639% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 9380961.84% |
| Exicure, Inc. | -1.42 Million USD | 79497.822% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 295095.039% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -41699.149% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 220479.578% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -1558.443% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 755299.289% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 2008.305% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -288859.335% |
| OmniAb, Inc. | 14.66 Million USD | -7603.218% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -5551.133% |
| Lipocine Inc. | -2.85 Million USD | 39731.818% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 61403.907% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 19904.224% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 75107.485% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -1400.121% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 1738301.538% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -1240.314% |
| Ocugen, Inc. | -33.53 Million USD | 3468.909% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 35831.531% |
| Q32 Bio Inc. | 578 Thousand USD | -195372.491% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 426451.321% |
| Alumis Inc. Common Stock | -1.28 Million USD | 88093.069% |
| Equillium, Inc. | 35.95 Million USD | -3042.085% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 66288.108% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -225559.754% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 27330312.869% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 436328.185% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -267181.506% |
| Dominari Holdings Inc. | 2.03 Million USD | -55311.035% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 615909.038% |
| vTv Therapeutics Inc. | -13.59 Million USD | 8410.636% |
| Bio-Techne Corporation | 773.07 Million USD | -46.148% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -6423.65% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -145.196% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 96749.358% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 4811.555% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -9559.152% |
| Nkarta, Inc. | -5.86 Million USD | 19350.826% |
| BioCardia, Inc. | -7.24 Million USD | 15686.026% |
| Iterum Therapeutics plc | -1.75 Million USD | 64661.771% |